Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 776–800 of 27,380 studies, newest first · page 32 of 1096.

August 2026 25

  1. 2026-08-10

    Rhabdomyolysis Secondary to Reactivated Herpes Simplex Virus Type 1 Coinfected with Klebsiella pneumoniae in an Elderly Patient: A Case Report

    ⚠ Preprint — not yet peer-reviewed Prevention and risk Research Square

    Key finding: After targeted anti-infection therapy, sufficient fluid resuscitation combined with nutritional and immune supportive care, the patient’s creatine kinase and inflammatory biomarkers normalized, and clinical status improved gradually. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  2. 2026-08-10

    Treatment of obstructive sleep apnea may contribute to long-term stabilisation of memory in Alzheimer's and vascular dementia

    ⚠ Preprint — not yet peer-reviewed Risk factors Research Square

    Key finding: Controlling for baseline differences, treatment of OSA improved delayed recall and may reduce the slope of memory decline in Alzheimer’s disease and vascular dementia. +2 more findings

    Scored 42 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  3. 2026-08-10

    Cognitive Stimulation and Training in People with Mild-to-Moderate Alzheimer’s Disease: A Scoping Review

    ⚠ Preprint — not yet peer-reviewed Cognitive tests and assessment Preprints.org

    Key finding: Of 352 records identified, five studies involving 245 participants were included. +4 more findings

    Scored 29 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  4. 2026-08-10

    A New Frontier in CWD Detection: Antemortem Plasma Biomarkers and Behavioral Profiling in Transgenic Mouse Models

    ⚠ Preprint — not yet peer-reviewed Biomarkers bioRxiv

    Key finding: Analyses at 90, 132, 174, and 230 days post-CWD inoculation show distinct biomarker elevation, with all three biomarkers significantly elevated in the CWD animals by 132 days post-inoculation. +1 more finding

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  5. 2026-08-10

    Social isolation, loneliness, and blood-based AD/ADRD biomarkers in a nationally-representative study of middle-aged and older adults

    ⚠ Preprint — not yet peer-reviewed Biomarkers medRxiv

    Key finding: Social isolation was associated with elevated blood-based biomarkers of neuronal injury, with variation by patterns of exposure over time. +4 more findings

    Scored 31 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  6. 2026-08-10

    Palliative care documentation in gastrointestinal bleeding hospitalizations: national trends and associated care patterns

    ✓ Peer-reviewed End-of-life care Baylor University Medical Center Proceedings

    Key finding: Among 2,435,099 weighted hospitalizations, palliative care documentation was present in 65,675 (2.70%), increasing from 2.13% in 2016 to 3.43% in 2022. +4 more findings

  7. 2026-08-10

    Plasma Biomarkers for Neocortical Tau Burden

    ✓ Peer-reviewed Biomarkers JAMA Neurology

    Key finding: The study included 560 amyloid-positive participants (BioFINDER: n = 431; mean [SD] age, 73.6 [7.0] years; 212 female [49.2%] and 219 male [51.8%]; TRIAD: n = 129; mean [SD] age, 70.4 [8.3] years; 76 female [58.9%] and 53 male [41.1%]). +4 more findings

  8. 2026-08-10

    Social and socioeconomic factors and cognitive outcomes in multiple sclerosis

    ✓ Peer-reviewed Risk factors Multiple Sclerosis and Related Disorders

    Key finding: Non-White race and adverse social and socioeconomic factors-lower education, unemployment, unmarried status, and greater neighborhood disadvantage-were each associated with poorer cognitive performance (p < 0.05). +3 more findings

  9. 2026-08-08

    Stress-Specific Mitochondrial Reserve as a Candidate Modifier of Lipid-Driven Synaptic Failure in Alzheimer Disease

    ✓ Peer-reviewed Treatments Zenodo (CERN European Organization for Nuclear Research)

    Key finding: A recent randomized trial demonstrated clear cerebrospinal-fluid DHA target engagement without detectable improvement in cognition or brain volume over 24 months. +4 more findings

  10. 2026-08-08

    Stress-Specific Mitochondrial Reserve as a Candidate Modifier of Lipid-Driven Synaptic Failure in Alzheimer Disease

    ✓ Peer-reviewed Treatments Zenodo (CERN European Organization for Nuclear Research)

    Key finding: A recent randomized trial demonstrated clear cerebrospinal-fluid DHA target engagement without detectable improvement in cognition or brain volume over 24 months. +4 more findings

  11. 2026-08-07

    Sex-divergent trajectories of hippocampal and cortical NMDA receptor density across the Alzheimer’s disease continuum

    ⚠ Preprint — not yet peer-reviewed Cognitive tests and assessment bioRxiv

    Key finding: While loss of NMDA receptors (NMDARs) is associated with Alzheimer’s disease (AD) severity, the effect of sex or the relationship between regional NMDAR density and antemortem cognitive status across the AD spectrum has not been examined. +2 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  12. 2026-08-07

    Conditional Latent Diffusion for Synthetic Brain MRI in Alzheimer’s Disease: A Preprocessing-Focused Pipeline

    ⚠ Preprint — not yet peer-reviewed Digital health tools Preprints.org

    Key finding: A classifier trained only on synthetic data achieved an area under the curve (AUC) of 0.754 (95% CI, 0.60 to 0.91), compared with 0.810 for real data.

    Scored 32 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  13. 2026-08-07
  14. 2026-08-07

    Relationships Among Hearing, Auditory Processing, and Cognition: A Study of Older Adults

    ✓ Peer-reviewed Risk factors Audiology research

    Key finding: DSI emerged as a significant predictor across both MoCA and CBB, surpassing the predictive power of both types of PTAs. +2 more findings

  15. 2026-08-07
  16. 2026-08-07

    Randomized metformin and cognitive outcomes in the Diabetes Prevention Program Outcomes Study

    ⚠ Preprint — not yet peer-reviewed Drug development medRxiv

    Key finding: Long-term metformin treatment is associated with a reduced risk of dementia and better memory performance among persons with pre-diabetes or T2D. Longer follow-up with more dementia cases is needed to confirm our findings. +4 more findings

    Scored 55 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  17. 2026-08-07

    Mapping Amyloid-PET Uptake in the White Matter in Alzheimer’s Disease

    ⚠ Preprint — not yet peer-reviewed Brain scans and imaging Research Square

    Key finding: This study investigated whether WM measures derived from amyloid-PET are associated with AD biomarkers and to determine whether they offer added diagnostic and prognostic value beyond established biomarkers. +4 more findings

    Scored 32 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  18. 2026-08-07

    Arterial Spin‐Labeling MRI at the Cortical‐ CSF Interface: A Novel Biomarker in Alzheimer Disease

    ✓ Peer-reviewed Brain scans and imaging Annals of Clinical and Translational Neurology

    Key finding: A total of 51 patients with AD, age (median: 73 years) and 53 cognitively normal subjects (median age: 69) were included. +4 more findings

  19. 2026-08-07

    Sensitivity and specificity of the CANTAB Paired Associates Learning test for identifying mild cognitive impairment

    ✓ Peer-reviewed Getting a diagnosis Acta Psychologica

    Key finding: Although the small sample size may have influenced the results, the findings suggest that the PAL demonstrated good diagnostic accuracy for distinguishing participants with MoCA-defined MCI.

  20. 2026-08-07

    Clinical Practice Outcomes With Lecanemab for Alzheimer Disease

    ✓ Peer-reviewed Treatments Neurology Open Access

    Key finding: ε4 noncarriers and those with lower baseline amyloid burden. +4 more findings

  21. 2026-08-07

    Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Alzheimer's & Dementia

    Key finding: Despite reductions in plasma p-tau217 with donanemab treatment, this biomarker cannot currently be used to accurately detect TRAC by PET (< 24.1 CL) in individuals with early symptomatic AD.

  22. 2026-08-06

    APP Dosage and Extracellular Domain Variants Drive Distinct Defects in Neurogenesis modeled in Down Syndrome iPS cells

    ⚠ Preprint — not yet peer-reviewed Down syndrome and Alzheimer's bioRxiv

    Key finding: Further analyses of the null and other mutant lines indicate that APP likely impacts these two distinct steps by two different mechanisms. +3 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  23. 2026-08-06

    Diffusion MRI of Gray Matter Microstructural Profiles in Healthy Aging

    ✓ Peer-reviewed Prevention trials Neuroscience and biobehavioral reviews

    Key finding: This methodology has historically been applied only to white matter tissue in the research context, but more recent literature suggests that diffusion MRI can also be applied to study microstructural alterations of gray matter tissue, including in healthy aging.

  24. 2026-08-06

    Discovery of Natural Cholinesterase Inhibitors via Integrated Computational Studies using Labdane-Related Diterpenoids-based Pharmacophore Model and in-vitro studies

    ⚠ Preprint — not yet peer-reviewed Treatments Research Square

    Key finding: In recent years, labdane- related diterpenoids have attracted significant attention for their reported anticholinesterase efficacy, in tandem with their anti-inflammatory, antioxidant, and neuroprotective properties. +2 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  25. 2026-08-06

    Semaglutide Activates the Orexin/Hypocretin and Basal Forebrain Cholinergic Systems and Increases Acetylcholine Levels in the Hippocampus of Young and Aged Rats

    ⚠ Preprint — not yet peer-reviewed Drug development bioRxiv

    Key finding: We found that the orexin/hypocretin and basal forebrain cholinergic systems are activated following acute semaglutide administration in male and female young adult rats (3-5 months). +1 more finding

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

Browse the library by subject, with the full score breakdown →